Insulet, Eli Lilly enter agreement to help patients with type 2 diabetes
Insulet Corp., a medical device company based in Bedford, will develop a pump specifically designed to deliver a concentrated form of insulin made by Eli Lilly and Co. for diabetics who need the drug in high doses, the two companies said Thursday.
Insulet makes a tubeless insulin pump known as the OmniPod Insulin Management System. The OmniPod is a small pump about half the size of a hard-boiled egg. Diabetics wear the pump, which uses an adhesive to stick to such places as shoulder blades and the side of the stomach. According to Insulet, the OmniPod system, is lighter, more convenient, and more effective for patients than earlier-generation insulin pumps.
As the incidence of severe insulin resistance continues to rise, more and more people with type 2 diabetes are requiring significantly higher doses of insulin in order to control their blood glucose, Insulet and Eli Lilly said in their press release. It was for this group of patients that Eli Lilly developed Humulin R U-500, a concentrated form of insulin.
Under Thursday’s agreement, Insulet will develop a new version of the OmniPod that is specifically designed to for use with Humulin R U-500.
MOST E-MAILED »
- Aerosmith, James Taylor, NKOTB and more line up to play ‘Boston Strong’ benefit for One Fund
- Jeff Vinik tells clients he will close hedge fund
- Teens training too hard, too often
- California wildfire grows to 43 square miles
- Shaved zucchini salad
- Urology group stops recommending routine PSA screening for men
- Dennis Lehane’s ‘Live by Night’ tops ‘Gone Girl’ for best novel of the year
